Over 10 years we help companies reach their financial and branding goals. Engitech is a values-driven technology agency dedicated.

Gallery

Contacts

411 University St, Seattle, USA

+1 -800-456-478-23

Brett Kaplan

Brett Kaplan, MD

// Board Director

Biography

Dr. Kaplan currently serves as the Chief Financial and Corporate Development Officer of Chroma Medicine Inc. He most recently served as Audit Committee Chair and Board member of Compass Therapeutics. Prior to joining Chroma, Dr. Kaplan was the Chief Financial Officer of Prevail Therapeutics, which was acquired by Eli Lilly in January 2021 for up to $1.04 billion. While at Prevail Therapeutics, Dr. Kaplan guided the company through crossover and IPO financing, raising $175 million. Previously, Dr. Kaplan was Managing Director at Evercore where he spent eight years focused on biopharma M&A and equity financings. Prior to Evercore, he was an Equity Research Analyst at Cowen, where he covered large cap pharmaceuticals. Earlier in his career, Dr. Kaplan held senior positions at Cubist and Lilly focused on corporate and business development. He holds an MBBCh and an MBA from the University of Witwatersrand in South Africa.